SUNSHINE PHARMA
0688740.2003.82% ( +1.480 )
Q4 FY2025 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: SUNSHINE PHARMA(06887) the Revenue is 1.6 B (+109.3%);the EBIT is 281.75 M (+262.6%);the EPS is 0.323 (+176.6%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
1.60B109.31%
----
----
EBIT
0.28B262.64%
----
----
EPS
0.3228176.55%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf